We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
XPeng
XPEV
$11.8B
| $43.7M | 0.2% |
1,195,927
+1,183,546
| +9,559% | +$49.2M |
|
102
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| $43.2M | 0.2% |
+318,700
| New | +$46.2M |
|
103
ExxonMobil
XOM
$651B
| $43.1M | 0.2% |
772,793
+304,294
| +65% | +$16M |
|
104
Endava
DAVA
$141M
| $43.1M | 0.2% |
508,769
-446,877
| -47% | -$37.3M |
|
105
BioLife Solutions
BLFS
$1.46B
| $42.3M | 0.19% |
1,176,033
+14,368
| +1% | +$568K |
|
106
CALL
Amazon
AMZN
$2.5T
| $41.5M | 0.19% |
+268,000
| New | +$42.5M |
|
107
S&P Global
SPGI
$126B
| $40.8M | 0.19% |
115,562
+8,621
| +8% | +$2.87M |
|
|
SGEN
108
DELISTED
Seagen Inc. Common Stock
SGEN
| $40.6M | 0.19% |
292,272
+152,025
| +108% | +$24.5M |
|
109
Yum China
YUMC
$14.9B
| $40.4M | 0.19% |
681,512
-556,114
| -45% | -$33.2M |
|
110
Vertex Pharmaceuticals
VRTX
$121B
| $40.1M | 0.18% |
186,728
-12,859
| -6% | -$2.82M |
|
111
DoorDash
DASH
$75.3B
| $40M | 0.18% |
+305,002
| New | +$51.1M |
|
|
TWTR
112
DELISTED
Twitter, Inc.
TWTR
| $40M | 0.18% |
+628,359
| New | +$38.4M |
|
113
Uber
UBER
$134B
| $39.9M | 0.18% |
732,860
+172,038
| +31% | +$9.6M |
|
|
GAP
114
The Gap Inc
GAP
$6.84B
| $39.9M | 0.18% |
1,340,998
+704,725
| +111% | +$17.5M |
|
|
WORK
115
DELISTED
Slack Technologies, Inc.
WORK
| $39.9M | 0.18% |
982,359
+41,390
| +4% | +$1.73M |
|
|
BBL
116
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $39.6M | 0.18% |
683,711
-390,823
| -36% | -$23.2M |
|
117
Live Nation Entertainment
LYV
$41.2B
| $39.6M | 0.18% |
467,315
+371,461
| +388% | +$29.9M |
|
118
Oracle
ORCL
$331B
| $39.5M | 0.18% |
+563,447
| New | +$36.5M |
|
119
Bank of Montreal
BMO
$125B
| $38.2M | 0.18% |
428,326
+72,474
| +20% | +$5.91M |
|
120
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $38.1M | 0.17% |
96,200
-550,500
| -85% | -$212M |
|
|
EXE
121
Expand Energy Corp
EXE
$21.9B
| $38M | 0.17% |
+874,647
| New | +$38.6M |
|
|
122
Alphabet (Google) Class A
GOOGL
$3.91T
| $37.2M | 0.17% |
360,640
-1,232,160
| -77% | -$122M |
|
123
Willis Towers Watson
WTW
$27.9B
| $37.1M | 0.17% |
162,089
-71,944
| -31% | -$15.7M |
|
124
TC Energy
TRP
$73.5B
| $36.8M | 0.17% |
803,558
+285,673
| +55% | +$12.7M |
|
125
VF Corp
VFC
$6.68B
| $36.8M | 0.17% |
459,893
+288,628
| +169% | +$23.4M |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.